Controlled substance Schedules I, II, III, IV and V are hereby established, which Schedules include the following, subject to amendment pursuant to Ohio R.C. 3719.43 or 3719.44.
SCHEDULE I
(a) Narcotics-Opiates. Any of the following opiates, including their isomers, esters, ethers, salts and salts of isomers, esters and ethers, unless specifically excepted under Federal drug abuse control laws, whenever the existence of these isomers, esters, ethers and salts is possible within the specific chemical designation:
(1) Acetyl-alpha-methylfentanyl (N- [1-(1-methyl-2-phenethyl-4-piperidinyl]-N-phenylacetamide);
(2) Acetylmethadol;
(3) Allylprodine;
(4) Alphacetylmethadol (except levo-alphacetylmethadol, also known as levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM);
(5) Alphameprodine;
(6) Alphamethadol;
(7) Alpha-methylfentanyl (n-[1-(alpha-methyl-beta-phenyl) ethyl-4-piper-idyl]propionanilide; 1-(1-methyl-2-phenylethyl)-4-(n-propanilido) piper-idine);
(8) Alpha-methylthiofentanyl (n-[1-methyl-2-(2-thienyl)ethyl-4-piper-idinyl]-n-phenylpropanamide);
(9) Benzethidine;
(10) Betacetylmethadol;
(11) Beta-hydroxyfentanyl (n-[1-(2-hydroxy-2-phenethyl-4-piperidinyl]-n- phenylpropanamide);
(12) Beta-hydroxy-3-methylfentanyl (other name: n-[1-(2-hydroxy-2-phen- ethyl)-3-methyl-4-piperidinyl]-nphenylpropanamide);
(13) Betameprodine;
(14) Betamethadol;
(15) Betaprodine;
(16) Clonitazene;
(17) Dextromoramide;
(18) Diampromide;
(19) Diethylthiambutene;
(20) Difenoxin;
(21) Dimenoxadol;
(22) Dimepheptanol;
(23) Dimethylthiambutene;
(24) Dioxaphetyl butyrate;
(25) Dipipanone;
(26) Ethylmethylthiambutene;
(27) Etonitazene;
(28) Etoxeridine;
(29) Furethidine;
(30) Hydroxypethidine;
(31) Ketobemidone;
(32) Levomoramide;
(33) Levophenacylmorphan;
(34) 3-methylfentanyl (n-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-n- phenyl-propanamide);
(35) 3-methylthiofentanyl (n-[3-methyl-1-[2-thienyl)ethyl]-4-piperidinyl]- n-phenylpropanamide);
(36) Morpheridine;
(37) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);
(38) Noracymethadol;
(39) Norlevorphanol;
(40) Normethadone;
(41) Norpipanone;
(42) Para-fluorofentanyl (n-(4-fluorophenyl)-n-[1-(2-phenethyl)-4-piper- idinyl] propanamide;
(43) PEPAP (1-(2-phenethyl)-4-phenyl-4-ace-toxypiperidine;
(44) Phenadoxone;
(45) Phenampromide;
(46) Phenomorphan;
(47) Phenoperidine;
(48) Piritramide;
(49) Proheptazine;
(50) Properidine;
(51) Propiram;
(52) Racemoramide;
(53) Thiofentanyl (n-phenyl-n-[1-(2-thienyl)ethyl-4-piperidinyl]- propanamide;
(54) Tilidine;
(55) Trimeperidine.
(b) Narcotics-Opium Derivatives. Any of the following opium derivatives, including their salts, isomers and salts of isomers, unless specifically excepted under Federal drug abuse control laws, whenever the existence of these salts, isomers and salts of isomers is possible within the specific chemical designation:
(1) Acetorphine; (14) Methyldihydromorphine;
(2) Acetyldihydrocodeine; (15) Morphine methylbromide;
(3) Benzylmorphine; (16) Morphine methylsulfonate;
(4) Codeine methylbromide; (17) Morphine-n-oxide;
(5) Codeine-n-oxide; (18) Myrophine;
(6) Cyprenorphine; (19) Nicocodeine;
(7) Desomorphine; (20) Nicomorphine;
(8) Dihydromorphine; (21) Normorphine;
(9) Drotebanol; (22) Pholcodeine;
(10) Etorphine (except (23) Thebacon.
hydrochloride salt);
(11) Heroin;
(12) Hydromorphinal;
(13) Methyldesorphine;
(c) Hallucinogens. Any material, compound, mixture or preparation that contains any quantity of the following hallucinogenic substances, including their salts, isomers and salts of isomers, unless specifically excepted under Federal drug abuse control laws, whenever the existence of these salts, isomers and salts of isomers is possible within the specific chemical designation. For the purposes of this subsection only, “isomer” includes the optical isomers, position isomers and geometric isomers:
(1) Alpha-ethyltryptamine (some trade or other names: etryptamine; Monase; alpha-ethyl-1H-indole-3-ethanamine; 3-(2-aminobutyl) indole; alpha-ET; and AET);
(2) 4-bromo-2,5-dimethoxy-amphetamine (some trade or other names: 4-bromo-2,5-dimethoxy-alpha-methyphenethylamine; 4-bromo-2,5-DMA);
(3) 4-bromo-2,5-dimethoxyphenethylamine (some trade or other names: 2-(4-bromo-2,5-dimethoxyphenyl)-1-aminoethane; alpha-desmethyl DOB; 2C-B, Nexus);
(4) 2,5-dimethoxyamphetamine (some trade or other names: 2,5-dimethoxy-alpha-methylphenethylamine; 2,5-DMA);
(5) 2,5-dimethoxy-4-ethylamphetamine (some trade or other names: DOET);
(6) 4-methoxyamphetamine (some trade or other names: 4-methoxy- alpha-methylphenethylamine; paramethoxy-amphetamine; PMA);
(7) 5-methoxy-3,4-methylenedioxy-amphetamine;
(8) 4-methyl-2,5-dimethoxy-amphetamine (some trade or other names: 4-methyl-2,5-dimethoxy-alpha-methyl-phenethylamine; “DOM” and “STP”);
(9) 3,4-methylenedioxy amphetamine;
(10) 3,4-methylenedioxymethamphetamine (MDMA);
(11) 3,4-methylenedioxy-n-ethyl-amphetamine (also known as n-ethyl- alpha-methyl-3,4(methylenedioxy) phenethylamine, n-ethyl MDA, MDE, MDEA);
(12) N-hydroxy-3,4-methylenedioxy-amphetamine (also known as n- hydroxy-alpha-methyl-3,4(methylenedioxy)phenethylamine and n-hydroxy (MDA);
(13) 3,4,5-trimethoxy amphetamine;
(14) Bufotenine (some trade or other names: 3-(beta- dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)-5-indolol; n, n-dimethyl- serotonin; 5-hydroxy-n, n-dimethyltryptamine; mappine);
(15) Diethyltryptamine (some trade or other names: n,n- diethyltryptamine; DET);
(16) Dimethyltryptamine (some trade or other names: DMT);
(17) Ibogaine (some trade or other names: 7-ethyl-6,6beta, 7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-5H-pyrido [1'2':1,2] azepino [5,4-b] indole; tabernanthe iboga);
(18) Lysergic acid diethylamide;
(19) Marihuana;
(20) Mescaline;
(21) Parahexyl (some trade or other names: 3-hexyl-1- hydroxy-7,8,9,10-tetra-hydro-6, 6, 9-trimethyl-6H-dibenzoab, dbpyran; synhexyl);
(22) Peyote (meaning all parts of the plant presently classified botanically as “lophophora williamsii lemaire,” whether growing or not, the seeds of that plant, any extract from any part of that plant, and every compound, manufacture, salts, derivative, mixture or preparation of that plant, its seeds or its extracts);
(23) N-ethyl-3-piperidyl benzilate;
(24) N-methyl-3-piperidyl benzilate;
(25) Psilocybin;
(26) Psilocyn;
(27) Tetrahydrocannabinols (synthetic equivalents of the substances contained in the plant, or in the resinous extractives of cannabis, sp. and/or synthetic substances, derivatives, and their isomers with similar chemical structure and pharmacological activity such as the following: delta-1-cis or trans tetrahydrocannabinol, and their optical isomers; delta-6-cis or trans tetrahydrocannabinol, and their optical isomers; delta-3,4-cis or trans tetrahydrocannabinol, and its optical isomers. (Since nomenclature of these substances is not internationally standardized, compounds of these structures, regardless of numerical designation of atomic positions, are covered.));
(28) Ethylamine analog of phencyclidine (some trade or other names: n- ethyl-1-phenylcyclohexylamine; (1-phenylcyclohexyl)ethylamine; n- (1-phenylcyclohexyl)ethylamine; cyclohexamine; PCE);
(29) Pyrrolidine analog of phencyclidine (some trade or other names: 1-(1-phenylcyclohexyl)pyrrolidine; PCPY; PHP);
(30) Thiophene analog of phencyclidine (some trade or other names: 1-[1-(2-thienyl)-cyclohexyl]-piperidine; 2-thienyl analog of phencyclidine; TPCP; TCP);
(31) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine;
(32) Hashish.
(d) Depressants. Any material, compound, mixture or preparation that contains any quantity of the following substances having a depressant effect on the central nervous system, including their salts, isomers and salts of isomers, unless specifically excepted under Federal drug abuse control laws, whenever the existence of these salts, isomers and salts of isomers is possible within the specific chemical designation:
(1) Mecloqualone;
(2) Methaqualone.
(e) Stimulants. Unless specifically excepted or unless listed in another Schedule, any material, compound, mixture or preparation that contains any quantity of the following substances having a stimulant effect on the central nervous system, including their salts, isomers and salts of isomers:
(1) Aminorex (some other names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline; or 4,5-dihydro-5-phenyl-2-oxazolamine);
(2) Cathinone (some trade or other names: 2-amino-1-phenyl-1-propanone, alpha-amino-propiophenone, 2-aminopropiophenone, and norephedrone);
(3) Fenethylline;
(4) Methcathinone (some other names: 2-(methylamino)-propiophenone; alpha-(methylamino)propiophenone; 2-methyl-amino)-1-phenylpropan-1-one; alpha-n- methylaminopropiophenone; monomethylpropion; ephedrone; n-methylcathinone; methylcathinone; AL-464; AL-422; AL-463; and UR1432), its salts, optical isomers, and salts of optical isomers;
(5) (+/-)cis-4-methylaminorex ((+/- )cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine);
(6) N-ethylamphetamine;
(7) N-n-dimethylamphetamine (also known as n, n-alpha-trimethyl- benzene-ethanamine; n,n-alpha-trimethylphenethylamine).
SCHEDULE II
(a) Narcotics-Opium and Opium Derivatives. Unless specifically excepted under Federal drug abuse control laws or unless listed in another Schedule, any of the following substances, whether produced directly or indirectly by extraction from substances of vegetable origin, independently by means of chemical synthesis or by a combination of extraction and chemical synthesis:
(1) Opium and opiate, and any salt, compound, derivative or preparation of opium or opiate, excluding apomorphine, thebaine-derived butorphanol, dextrorphan, naluphine, nalmefene, naloxone, and naltrexone, and their respective salts, but including the following:
A. Raw opium;
B. Opium extracts;
C. Opium fluid extracts;
D. Powdered opium;
E. Granulated opium;
F. Tincture of opium;
G. Codeine;
H. Ethylmorphine;
I. Etorphine hydrochloride;
J. Hydrocodone;
K. Hydromorphone;
L. Metopon;
M. Morphine;
N. Oxycodone;
O. Oxymorphone;
P. Thebaine.
(2) Any salt, compound, derivative or preparation thereof that is chemically equivalent to or identical with any of the substances referred to in subsection (a)(1) of this Schedule, except that these substances shall not include the isoquinoline alkaloids of opium;
(3) Opium poppy and poppy straw;
(4) Coca leaves and any salt, compound, derivative or preparation of coca leaves (including cocaine and ecgonine, their salts, isomers and derivatives, and salts of those isomers and derivatives), and any salt, compound, derivative or preparation thereof that is chemically equivalent to or identical with any of these substances, except that the substances shall not include decocainized coca leaves or extraction of coca leaves, which extractions do not contain cocaine or ecgonine;
(5) Concentrate of poppy straw (the crude extract of poppy straw in either liquid, solid or powder form that contains the phenanthrene alkaloids of the opium poppy).
(b) Narcotics-Opiates. Unless specifically excepted under Federal drug abuse control laws or unless listed in another Schedule, any of the following opiates, including their isomers, esters, ethers, salts and salts of isomers, esters and ethers whenever the existence of these isomers, esters, ethers and salts is possible within the specific chemical designation, but excluding dextrorphan and levopropoxyphene:
(1) Alfentanil;
(2) Alphaprodine;
(3) Anileridine;
(4) Bezitramide;
(5) Bulk dextropropoxyphene (non-dosage forms);
(6) Carfentanil;
(7) Dihydrocodeine;
(8) Diphenoxylate;
(9) Fentanyl;
(10) Isomethadone;
(11) Levo-alphacetylmethadol (some other names: levo-alpha- acetylmetha-dol, levomethadyl acetate, LAAM);
(12) Levomethorphan;
(13) Levorphanol;
(14) Metazocine;
(15) Methadone;
(16) Methadone-intermediate, 4-cyano-2-dimethylamino-4,4-diphenyl butane;
(17) Moramide-intermediate,2-methyl-3-morpholino-1,1 diphenylpropane- car-boxylic acid;
(18) Pethidine (meperidine);
(19) Pethidine-intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine;
(20) Pethidine-intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate;
(21) Pethidine-intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid;
(22) Phenazocine;
(23) Piminodine;
(24) Racemethorphan;
(25) Racemorphan;
(26) Remifentanil;
(27) Sufentanil.
(c) Stimulants. Unless specifically excepted under Federal drug abuse control laws or unless listed in another Schedule, any material, compound, mixture or preparation that contains any quantity of the following substances having a stimulant effect on the central nervous system:
(1) Amphetamine, its salts, its optical isomers and salts of its optical isomers;
(2) Methamphetamine, its salts, its isomers and salts of its isomers;
(3) Methylphenidate;
(4) Phenmetrazine and its salts.
(d) Depressants. Unless specifically excepted under Federal drug abuse control laws or unless listed in another Schedule, any material, compound, mixture or preparation that contains any quantity of the following substances having a depressant effect on the central nervous system, including their salts, isomers and salts of isomers whenever the existence of these salts, isomers and salts of isomers is possible within the specific chemical designation:
(1) Amobarbital;
(2) Gamma-hydroxy-butyrate;
(3) Glutethimide;
(4) Pentobarbital;
(5) Phencyclidine (some trade or other names: 1-(1-phenylcyclohexyl)- piperidine; PCP);
(6) Secobarbital;
(7) 1-aminophenylcyclohexane and all n-mono-substituted and/or all n-n- disubstituted analogs, including, but not limited to, the following:
A. 1-phenylcyclohexylamine;
B. (1-phenylcyclohexyl) methylamine;
C. (1-phenylcyclohexyl) dimethylamine;
D. (1-phenylcyclohexyl) methylethylamine;
E. (1-phenylcyclohexyl) isopropylamine;
F. 1-(1-phenylcyclohexyl) morpholine.
(e) Hallucinogenic Substances.
(1) Nabilone (another name for nabilone: (+)- trans-3-(1,1-dimethylhepthyl), 6,6A-7,8,10,10A-hexahydro-1-hydroxy-6,6,dimethyl-9H- dibenzoab, dbpyran-9-one).
(f) Immediate Precursors. Unless specifically excepted under Federal drug abuse control laws or unless listed in another Schedule, any material, compound, mixture or preparation that contains any quantity of the following substances:
(1) Immediate precursor to amphetamine and methamphetamine: phenyl-acetone (some trade or other names: phenyl-2-propanone; P2P; benzyl methyl ketone; methyl benzyl ketone);
(2) Immediate precursors to phencyclidine (PCP);
A. 1-phenylcyclohexylamine;
B. 1-piperidinocyclohexanecarbonitrile (PCC).
SCHEDULE III
(a) Stimulants. Unless specifically excepted under Federal drug abuse control laws or unless listed in another Schedule, any material, compound, mixture or preparation that contains any quantity of the following substances having a stimulant effect on the central nervous system, including their salts, their optical isomers, position isomers or geometric isomers, and salts of these isomers whenever the existence of these salts, isomers and salts of isomers is possible within the specific chemical designation:
(1) All stimulant compounds, mixtures and preparations included in Schedule III pursuant to the Federal drug abuse control laws and regulations adopted under those laws;
(2) Benzphetamine;
(3) Chlorphentermine;
(4) Clortermine;
(5) Phendimetrazine.
(b) Depressants. Unless specifically excepted under Federal drug abuse control laws, or unless listed in another Schedule, any material, compound, mixture or preparation that contains any quantity of the following substances having a depressant effect on the central nervous system:
(1) Any compound, mixture or preparation containing amobarbital, secobarbital, pentobarbital, or any salt of any of these drugs, and one or more other active medicinal ingredients that are not listed in any Schedule;
(2) Any suppository dosage form containing amobarbital, secobarbital, pentobarbital, or any salt of any of these drugs, and approved by the Food and Drug Administration for marketing only as a suppository;
(3) Any substance that contains any quantity of a derivative of barbituric acid or any salt of a derivative of barbituric acid;
(4) Chlorhexadol;
(5) Ketamine, its salts, isomers and salts of isomers (some other names for ketamine: (+/-)-2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone);
(6) Lysergic acid;
(7) Lysergic acid amide;
(8) Methyprylon;
(9) Sulfondiethylmethane;
(10) Sulfonethylmethane;
(11) Sulfonmethane;
(12) Tilatamine, zolazepam, or any salt of tiletamine or zolazepam (some trade or other names for a tiletamine-zola-zepam combination product: telazol); (some trade or other names for tiletamine: 2-(ethylamino)-2-(2-thienyl)-cyclohexanone); (some trade or other names for zolazepam: 4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo- [3,4-e][1,4]diazepin-7(1H)-one;flupyrazapon).
(c) Narcotic Antidotes.
(1) Nalorphine.
(d) Narcotics-Narcotic Preparations. Unless specifically excepted under Federal drug abuse control laws, or unless listed in another Schedule, any material, compound, mixture or preparation that contains any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below:
(1) Not more than 1.8 grams of codeine per 100 milliliters or not more than ninety milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium;
(2) Not more than 1.8 grams of codeine per 100 milliliters or not more than ninety milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts;
(3) Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more than fifteen milligrams per dosage unit, with a fourfold or greater quantity of any isoquinoline alkaloid of opium;
(4) Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more than fifteen milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts;
(5) Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more than ninety milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts;
(6) Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more than fifteen milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts;
(7) Not more than 500 milligrams of opium per 100 milliliters or per 100 grams or not more than twenty-five milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts;
(8) Not more than fifty milligrams of morphine per 100 milliliters or per 100 grams, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts.
(e) Anabolic Steroids. Unless specifically excepted under Federal drug abuse control laws or unless listed in another Schedule, any material, compound, mixture or preparation that contains any quantity of the following substances, including their salts, esters, isomers and salts of esters and isomers whenever the existence of these salts, esters and isomers is possible within the specific chemical designation.
Except as otherwise provided in this subsection (e), “anabolic steroids” mens any drug or hormonal substance that is chemically and pharma-cologically related to testosterone (other than estrogens, progestins and corticosteroids) and that promotes muscle growth. “Anabolic steroids” does not include an anabolic steroid that is expressly intended for administration through implants to cattle or other nonhuman species and that has been approved by the United States Secretary of Health and Human Services for that administration, unless a person prescribes, dispenses or distributes this type of anabolic steroid for human use. “Anabolic steroid” includes, but is not limited to, the following:
(1) Boldenone;
(2) Chlorotestosterone (4-chlortestosterone);
(3) Clostebol;
(4) Dehydrochlormethyltestosterone;
(5) Dihydrotestosterone (4-dihydrotestosterone);
(6) Drostanolone;
(7) Ethylestrenol;
(8) Fluoxymesterone;
(9) Formebulone (formebolone);
(10) Mesterolone;
(11) Methandienone;
(12) Methandranone;
(13) Methandriol;
(14) Methandrostenolone;
(15) Methenolone;
(16) Methyltestosterone;
(17) Mibolerone;
(18) Nandrolone;
(19) Norethandrolone;
(20) Oxandrolone;
(21) Oxymesterone;
(22) Oxymetholone;
(23) Stanolone;
(24) Stanozolol;
(25) Testolactone;
(26) Testosterone;
(27) Trenbolone;
(28) Any salt, ester, isomer, or salt of an ester or isomer of a drug or hormonal substance described or listed in this subsection (e) if the salt, ester or isomer promotes muscle growth.
(f) Hallucinogenic Substances.
(1) Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a United States Food and Drug Administration - approved drug product (some other names for dronabinol: (6aR-trans)-6a,7,8,10a- tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol, or (-)-delta-9-(trans)- tetrahydrocannabinol).
SCHEDULE IV
(a) Narcotic Drugs. Unless specifically excepted by Federal drug abuse control laws or unless listed in another Schedule, any material, compound, mixture or preparation that contains any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below:
(1) Not more than one milligram of difenoxin and not less than twenty- five micrograms of atropine sulfate per dosage unit;
(2) Dextropropoxyphene (alpha- (+)-4-dimethylamino-1,2-diphenyl-3-methyl-2-propionoxybutane).
(b) Depressants. Unless specifically excepted under Federal drug abuse control laws or unless listed in another Schedule, any material, compound, mixture or preparation that contains any quantity of the following substances, including their salts, isomers and salts of isomers whenever the existence of these salts, isomers and salts of isomers is possible within the specific chemical designation:
(1) Alprazolam;
(2) Barbital;
(3) Bromazepam;
(4) Camazepam;
(5) Chloral betaine;
(6) Chloral hydrate;
(7) Chlordiazepoxide;
(8) Clobazam;
(9) Clonazepam;
(10) Clorazepate;
(11) Clotiazepam;
(12) Cloxazolam;
(13) Delorazepam;
(14) Diazepam;
(15) Estazolam;
(16) Ethchlorvynol;
(17) Ethinamate;
(18) Ethyl loflazepate;
(19) Fludiazepam;
(20) Flunitrazepam;
(21) Flurazepam;
(22) Halazepam;
(23) Haloxazolam;
(24) Ketazolam;
(25) Loprazolam;
(26) Lorazepam;
(27) Lormetazepam;
(28) Mebutamate;
(29) Medazepam;
(30) Meprobamate;
(31) Methohexital;
(32) Methylphenobarbital (mephobarbital);
(33) Midazolam;
(34) Nimetazepam;
(35) Nitrazepam;
(36) Nordiazepam;
(37) Oxazepam;
(38) Oxazolam;
(39) Paraldehyde;
(40) Petrichloral;
(41) Phenobarbital;
(42) Pinazepam;
(43) Prazepam;
(44) Quazepam;
(45) Temazepam;
(46) Tetrazepam;
(47) Triazolam;
(48) Zaleplon;
(49) Zolpidem.
(c) Fenfluramine. Any material, compound, mixture or preparation that contains any quantity of the following substances, including their salts, their optical isomers, position isomers or geometric isomers, and salts of these isomers, whenever the existence of these salts, isomers and salts of isomers is possible within the specific chemical designation:
(1) Fenfluramine.
(d) Stimulants. Unless specifically excepted under Federal drug abuse control laws or unless listed in another Schedule, any material, compound, mixture or preparation that contains any quantity of the following substances having a stimulant effect on the central nervous system, including their salts, their optical isomers, position isomers, or geometric isomers, and salts of these isomers whenever the existence of these salts, isomers and salts of isomers is possible within the specific chemical designation:
(1) Cathine ((+)-norpseudoephedrine);
(2) Diethylpropion;
(3) Fencamfamin;
(4) Fenproporex;
(5) Mazindol;
(6) Mefenorex;
(7) Modafinil;
(8) Pemoline (including organometallic complexes and chelates thereof);
(9) Phentermine;
(10) Pipradrol;
(11) Sibutramine;
(12) Spa [(-)-1-dimethylamino-1,2-diphenylethane].
(e) Other Substances. Unless specifically excepted under Federal drug abuse control laws or unless listed in another Schedule, any material, compound, mixture or preparation that contains any quantity of the following substances, including their salts:
(1) Pentazocine;
(2) Butorphanol (including its optical isomers).
SCHEDULE V
(a) Narcotic Drugs. Unless specifically excepted under Federal drug abuse control laws or unless listed in another Schedule, any material, compound, mixture or preparation that contains any of the following narcotic drugs, and their salts, as set forth below:
(1) Buprenorphine.
(b) Narcotics-Narcotic Preparations. Narcotic drugs containing nonnarcotic active medical ingredients. Any compound, mixture or preparation that contains any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below, and that includes one or more nonnarcotic active medicinal ingredients in sufficient proportion to confer upon the compound, mixture or preparation valuable medicinal qualities other than those possessed by narcotic drugs alone:
(1) Not more than 200 milligrams of codeine per 100 milliliters or per 100 grams;
(2) Not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100 grams;
(3) Not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100 grams;
(4) Not more than 2.5 milligrams of diphenoxylate and not less than twenty-five micrograms of atropine sulfate per dosage unit;
(5) Not more than 100 milligrams of opium per 100 milliliters or per 100 grams;
(6) Not more than 0.5 milligram of difenoxin and not less than twenty- five micrograms of atropine sulfate per dosage unit.
(c) Stimulants. Unless specifically exempted or excluded under Federal drug abuse control laws or unless listed in another Schedule, any material, compound, mixture or preparation that contains any quantity of the following substances having a stimulant effect on the central nervous system, including their salts, isomers and salts of isomers:
(1) Ephidrene, except as provided in Ohio R.C. 3719.44(K);
(2) Pyrovalerone. (ORC 3719.41)